High Dose Rate Endorectal Brachytherapy as a Neoadjuvant Treatment for Patients with Resectable Rectal Cancer

Clinical Oncology

Volumn 19, Issue 9, 2007, Pages 701-705

  Vuong, T ^a   Devic, S ^a   Podgorsak, E ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Downsizing; downstaging; high dose endorectal brachytherapy; preoperative treatment; rectal cancer; toxicity

Indexed keywords

FLUOROURACIL;

ARTICLE; BLOOD TRANSFUSION; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTINUOUS INFUSION; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE; RECTUM CANCER; RECTUM CARCINOMA; RECTUM SURGERY; RECURRENCE RISK; RECURRENT CANCER; TREATMENT DURATION;

BRACHYTHERAPY; HUMANS; NEOADJUVANT THERAPY; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 34748856738     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.07.006     Document Type: Article

References (38)

1. Heald R.J. The holy plane of rectal surgery. J R Soc Med 81 (1988) 503
2. Heald R., Moran B., Ryall R., Sexton R., and MacFarlane J. Rectal cancer. The Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 133 (1998) 894-899
3. Enker W., Thaler H., Cranor M., and Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181 (1995) 335-346
4. Enker W.E. Total mesorectal excision with sphincter and autonomic nerve preservation in the treatment of rectal cancer. Curr Tech Gen Surg 5 (1996) 1-8
5. Macfarlane J.K., Ryall R.D., and Heald R.J. Mesorectal excision for rectal cancer. Lancet 341 (1993) 457-460
6. Martling A.L., Holm T., Rutqvist L.E., Moran B.J., Heald R.J., and Cedemark B. Effects of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 356 (2000) 93-96
7. Dahlberg M., Glimelius B., and Pahlman L. Changing strategy for rectal cancer associated with improved outcome. Br J Surg 86 (1999) 379-384
8. Merchant N., Guillem J., Paty P., et al. T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg 3 (1999) 642-647
9. Kapiteijn E., Marijnen C.A.M., Nagtegall I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
10. Camma C., Giunta M., Fiorica F., Paglioaro L., Craxi A., and Cottone M. Preoperative radiotherapy for resectable rectal cancer. J Am Med Assoc 284 (2000) 1008-1015
11. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomized trials. Lancet 358 (2001) 1291-1304
12. Sobin L.H., and Wittekind C. UICC TNM classification of malignant tumours. 5th edn (1997), Wiley, New York 66-69
13. National Cancer Institute. Common Toxicity Criteria, version 2.0 September 1998.
14. Vuong T., Devic S., Moftah B., Evans M., and Podgorsak E.B. High dose rate endorectal brachytherapy in the treatment of locally advanced rectal carcinoma: technical aspects. Brachytherapy 4 (2005) 230-235
15. Patel S., Vuong T., Ballivy O., Portelance L., Parker W., and Patrocinio H. Phase II trial of pelvic intensity modulated radiotherapy (IMRT) with concurrent chemotherapy for patients with rectal cancer. Int J Radiat Oncol Biol 60 (2004) S424
16. Vuong T., Belliveau P., Michel R., et al. Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer. Dis Colon Rectum 45 (2002) 1486-1495
17. Sauer C., Martus P., Papadoupolos T., et al. Prognostic significance of tumor regression after preoperative chemo-radiotherapy for rectal cancer. J Clin Oncol 23 (2005) 8688-8696
18. Wiltshire K., Ward I.G., Swallow C., et al. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathological complete response, local recurrence-free survival, disease free survival and overall survival. Int J Radiat Oncol Biol 64 (2006) 709-716
19. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
20. Gerard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
21. Berger C., De Muret A., Garaud P., et al. Preoperative radiotherapy for rectal cancer: predictive factors of tumor downstaging and residual tumor density (RTCD): prognostic implications. Int J Radiat Oncol Biol 37 (1997) 619-627
22. Kaminsky-Forrett M.C., Conroy T., Luporsi E., et al. Prognostic implications of downstaging following radiation therapy for operable T3-4 rectal cancer. Int J Radiat Oncol Biol 42 (1998) 935-941
23. Janjan N., Abbruzzese J., Pazdur R., et al. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol 51 (1999) 153-160
24. Modiuddin M., Hayne M., Regine W., et al. Prognostic significance of post-chemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol 48 (2000) 1075-1080
25. Valentini V., Coco C., Picciocchi A., et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol 53 (2002) 664-674
26. Brown C., Ternent C., Thorson A., et al. Response to preoperative chemoradiation in stage II and III rectal cancer. Dis Colon Rectum 46 (2003) 1189-1193
27. Garcia-Aiguilar J., Hernandez de Anda E., Sirivongs P., et al. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 46 (2003) 298-304
28. Mohiuddin M., Winter K., Mitchell E., et al. Randomized phase II study of neoadjuvant combined chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group trial 0012. J Clin Oncol 24 (2006) 650-655
29. Gerard J.P., Chapet O., Nemoz C., et al. Preoperative concurrent chemradiotherapy in locally advanced rectal cancer with high dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol 21 (2003) 1119-1124
30. Rodel C., Grabenbauer G., Papadopoulod T., et al. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21 (2003) 3098-3104
31. Mehta V., Cho C., Ford J., et al. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11 followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol 55 (2003) 132-137
32. Read T., McNevin M., Gross E., et al. Neo-adjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity. Dis Colon Rectum 44 (2001) 513-522
33. Ooi B., Tjandra J., and Green M. Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer. Dis Colon Rectum 42 (1999) 403-418
34. Myerson R., Picus J., and Read T. Combining chemotherapy with radiation in the adjuvant care of rectal cancer: morbidity of treatment and its impact on management decisions. Perspect Colon Rect Surg 12 (2000) 113-129
35. Navarro M., Dotor E., Rivera F., et al. A phase II study of preoperative radiotherapy and concomitant weekly Irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer. Int J Radiat Oncol Biol 66 (2006) 201-205
36. Ryan D., Niedzwiecki D., Hollis D., et al. Phase I/II study of preoperative oxaliplatin, fluoruracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol 24 (2006) 2557-2562
37. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. J Am Med Assoc 264 (1990) 1444-1450
38. Glimelius B., Isacsson U., Jung B., and Pahlman L. Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose response effect favouring preoperative treatment. Int J Radiat Oncol Biol Phys 37 (1997) 281-287